2021
DOI: 10.1111/jth.15496
|View full text |Cite
|
Sign up to set email alerts
|

Proteome and functional decline as platelets age in the circulation

Abstract: Background Platelets circulate in the blood of healthy individuals for approximately 7–10 days regulated by finely balanced processes of production and destruction. As platelets are anucleate we reasoned that their protein composition would change as they age and that this change would be linked to alterations in structure and function. Objective To isolate platelets of different ages from healthy individuals to test the hypothesis that changes in protein content cause alterations in platelet structure and fun… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
52
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 33 publications
(61 citation statements)
references
References 77 publications
(126 reference statements)
9
52
0
Order By: Relevance
“…Functional relevance of low levels of platelet protein synthesis is challenged by the fact that platelets lose around half of their total protein content over the course of their circulating life. 43 An alternative source of S100A8 and S100A9 are megakaryocytes. While recent single-cell transcriptomic analysis of primary human megakaryocytes found S100A8 and S100A9 to be differentially expressed in 32 N compared with 4 N megakaryocytes, no increase in these transcripts was seen in megakaryocytes harvested at the time of MI.…”
Section: Discussionmentioning
confidence: 99%
“…Functional relevance of low levels of platelet protein synthesis is challenged by the fact that platelets lose around half of their total protein content over the course of their circulating life. 43 An alternative source of S100A8 and S100A9 are megakaryocytes. While recent single-cell transcriptomic analysis of primary human megakaryocytes found S100A8 and S100A9 to be differentially expressed in 32 N compared with 4 N megakaryocytes, no increase in these transcripts was seen in megakaryocytes harvested at the time of MI.…”
Section: Discussionmentioning
confidence: 99%
“…CD31 expression shows large interindividual variation, and high levels correlate with low platelet reactivity to CLEC‐2 and GPVI agonists [34]. Moreover, CD31 and GPVI levels decline as platelets age in the circulation, so these markers may be useful for discriminating young and old platelets [53].…”
Section: Constitutive Platelet Markersmentioning
confidence: 99%
“…The youngest platelet subtype released into the circulation appears to be more reactive and shows an increased tendency to recruit other platelets and immune cells to the site of injury. The newly formed platelets contain a residual amount of the megakaryocytic messenger RNA (mRNA) that gives them a greater array of functional pathways ( 26 ). As platelets age, the total protein content is degraded or lost without the possibility for replacement leaving old platelets with several biological alterations in function ( 26 ).…”
Section: Platelet Subtypesmentioning
confidence: 99%
“…The newly formed platelets contain a residual amount of the megakaryocytic messenger RNA (mRNA) that gives them a greater array of functional pathways ( 26 ). As platelets age, the total protein content is degraded or lost without the possibility for replacement leaving old platelets with several biological alterations in function ( 26 ). Differences related to platelet age propose a young platelet subpopulation that are rapid hemostatic responders and an old platelet population with higher apoptosis and senescence.…”
Section: Platelet Subtypesmentioning
confidence: 99%
See 1 more Smart Citation